ter Heine, R <br/><br/>
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Mar 2012 
 - 391-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2011.10.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Erlotinib Hydrochloride<br/>Fatal Outcome<br/>Gefitinib<br/>Humans<br/>Lung Diseases, Interstitial--chemically induced<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Myocardial Infarction--diagnosis<br/>Pleural Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--adverse effects<br/>Quinazolines--adverse effects